Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 82

Similar articles for PubMed (Select 20683317)

1.

Flexible use of CCR5 in the absence of CXCR4 use explains the immune deficiency in HIV-1 infected children.

Cavarelli M, Karlsson I, Ripamonti C, Plebani A, Fenyo EM, Scarlatti G.

AIDS. 2010 Oct 23;24(16):2527-33. doi: 10.1097/QAD.0b013e32833d7d8c.

PMID:
20683317
2.

HIV-1 accessory proteins adapt cellular adaptors to facilitate immune evasion.

Collins DR, Collins KL.

PLoS Pathog. 2014 Jan;10(1):e1003851. doi: 10.1371/journal.ppat.1003851. Epub 2014 Jan 23. Review. No abstract available.

3.

Transmission of the X4 phenotype of HIV-1: is there evidence against the "random transmission" hypothesis?

Hedskog C, Mild M, Albert J.

J Infect Dis. 2012 Jan 15;205(2):163-5. doi: 10.1093/infdis/jir719. Epub 2011 Dec 5. No abstract available.

4.

Reply to Ganesan et al.

Grubb JR, Overton ET, Presti R, Onen NF.

J Infect Dis. 2012 Feb 1;205(3):518-9. doi: 10.1093/infdis/jir758. Epub 2011 Nov 28. No abstract available.

5.

HIV-1 co-receptor usage: influence on mother-to-child transmission and pediatric infection.

Cavarelli M, Scarlatti G.

J Transl Med. 2011 Jan 27;9 Suppl 1:S10. doi: 10.1186/1479-5876-9-S1-S10. Review.

6.

Emergence, dominance, and possible decline of CXCR4 chemokine receptor usage during the course of HIV infection.

Meehan CJ, Hedge JA, Robertson DL, McCormack GP, Travers SA.

J Med Virol. 2010 Dec;82(12):2004-12. doi: 10.1002/jmv.21922.

PMID:
20981786
7.

CXCR4-using viruses in plasma and peripheral blood mononuclear cells during primary HIV-1 infection and impact on disease progression.

Raymond S, Delobel P, Mavigner M, Cazabat M, Encinas S, Souyris C, Bruel P, Sandres-Sauné K, Marchou B, Massip P, Izopet J.

AIDS. 2010 Sep 24;24(15):2305-12. doi: 10.1097/QAD.0b013e32833e50bb.

PMID:
20808203
8.

Potent in vitro inactivation of both free and cell-associated CCR5- and CXCR4-tropic HIV-1 by common commercial soap bars from South Africa.

Jenabian MA, Auvert B, Saïdi H, Lissouba P, Matta M, Bélec L.

J Acquir Immune Defic Syndr. 2010 Aug;54(4):340-2. doi: 10.1097/QAI.0b013e3181e3dbf6.

PMID:
20517160
9.

Molecular characterization of the env gene of two CCR5/CXCR4-independent human immunodeficiency 2 primary isolates.

Santos-Costa Q, Parreira R, Moniz-Pereira J, Azevedo-Pereira JM.

J Med Virol. 2009 Nov;81(11):1869-81. doi: 10.1002/jmv.21619.

PMID:
19774680
10.

[Prediction of phenotype R5/X4 of HIV-1 variants circulating in Russia, by using computer methods].

Vasil'ev AV, Kazennova EV, Bobkova MR.

Vopr Virusol. 2009 May-Jun;54(3):17-21. Russian.

PMID:
19537092
11.

Differences in molecular evolution between switch (R5 to R5X4/X4-tropic) and non-switch (R5-tropic only) HIV-1 populations during infection.

Mild M, Kvist A, Esbjörnsson J, Karlsson I, Fenyö EM, Medstrand P.

Infect Genet Evol. 2010 Apr;10(3):356-64. doi: 10.1016/j.meegid.2009.05.003. Epub 2009 May 14.

PMID:
19446658
12.

Presence of HIV-1 R5 viruses in cerebrospinal fluid even in patients harboring R5X4/X4 viruses in plasma.

Soulié C, Tubiana R, Simon A, Lambert-Niclot S, Malet I, Canestri A, Brunet C, Murphy R, Katlama C, Calvez V, Marcelin AG.

J Acquir Immune Defic Syndr. 2009 May 1;51(1):60-4. doi: 10.1097/QAI.0b013e31819fb903.

PMID:
19390328
13.

HIV-1 with multiple CCR5/CXCR4 chimeric receptor use is predictive of immunological failure in infected children.

Cavarelli M, Karlsson I, Zanchetta M, Antonsson L, Plebani A, Giaquinto C, Fenyö EM, De Rossi A, Scarlatti G.

PLoS One. 2008 Sep 29;3(9):e3292. doi: 10.1371/journal.pone.0003292.

14.

Chemokine (C-C motif) receptor 5-using envelopes predominate in dual/mixed-tropic HIV from the plasma of drug-naive individuals.

Irlbeck DM, Amrine-Madsen H, Kitrinos KM, Labranche CC, Demarest JF.

AIDS. 2008 Jul 31;22(12):1425-31. doi: 10.1097/QAD.0b013e32830184ba.

PMID:
18614865
15.

Downregulation of CCR5 on activated CD4 T cells in HIV-infected Indians.

Dubey S, Khalid M, Wesley C, Khan SA, Wanchu A, Jameel S.

J Clin Virol. 2008 Sep;43(1):25-31. doi: 10.1016/j.jcv.2008.03.026. Epub 2008 May 6.

PMID:
18462992
16.

The impact of HIV tropism on decreases in CD4 cell count, clinical progression, and subsequent response to a first antiretroviral therapy regimen.

Waters L, Mandalia S, Randell P, Wildfire A, Gazzard B, Moyle G.

Clin Infect Dis. 2008 May 15;46(10):1617-23. doi: 10.1086/587660.

17.

Evolution of DC-SIGN use revealed by fitness studies of R5 HIV-1 variants emerging during AIDS progression.

Borggren M, Repits J, Kuylenstierna C, Sterjovski J, Churchill MJ, Purcell DF, Karlsson A, Albert J, Gorry PR, Jansson M.

Retrovirology. 2008 Mar 27;5:28. doi: 10.1186/1742-4690-5-28.

18.

Biological and genetic evolution of HIV type 1 in two siblings with different patterns of disease progression.

Ripamonti C, Leitner T, Laurén A, Karlsson I, Pastore A, Cavarelli M, Antonsson L, Plebani A, Fenyö EM, Scarlatti G.

AIDS Res Hum Retroviruses. 2007 Dec;23(12):1531-40.

PMID:
18160011
19.

HIV-1 escape to CCR5 coreceptor antagonism through selection of CXCR4-using variants in vitro.

Moncunill G, Armand-Ugón M, Pauls E, Clotet B, Esté JA.

AIDS. 2008 Jan 2;22(1):23-31.

PMID:
18090388
20.

HIV-1 X4/R5 co-receptor in viral reservoir during suppressive HAART.

Soulié C, Marcelin AG, Ghosn J, Amellal B, Assoumou L, Lambert S, Duvivier C, Costagliola D, Katlama C, Calvez V.

AIDS. 2007 Oct 18;21(16):2243-5.

PMID:
18090053
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk